Untangling Amyloid-β, Tau, and Metals in Alzheimer's Disease

被引:343
|
作者
Savelieff, MG
Lee, S
Liu, YZ
Lim, MH [1 ]
机构
[1] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
基金
美国国家科学基金会;
关键词
A-BETA; OXIDATIVE STRESS; STRUCTURAL-CHARACTERIZATION; NEUROFIBRILLARY TANGLES; IN-VIVO; PROTEIN; AGGREGATION; PEPTIDE; BINDING; PHOSPHORYLATION;
D O I
10.1021/cb400080f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein misfolding and metal ion dyshomeostasis are believed to underlie numerous neurodegenerative diseases, including Alzheimer's disease (AD). The pathological hallmark of AD is accumulation of misfolded amyloid-beta (A beta) peptides and hyperphosphorylated tau (ptau) proteins in the brain. Since AD etiology remains unclear, several hypotheses have emerged to elucidate its pathological pathways. The amyloid cascade hypothesis, a leading hypothesis for AD development, advocates A beta as the principal culprit. Additionally, evidence suggests that tau may contribute to AD pathology. A beta and tau have also been shown to impact each other's pathology either directly or indirectly. Furthermore, metal ion dyshomeostasis is associated with these misfolded proteins. Metal interactions with A beta and tau/ptau also influences their aggregation properties and neurotoxicity. Herein, we present current understanding on the roles of A beta, tau, and metal ions, placing equal emphasis on each of these proposed features, as well as their inter-relationships in AD pathogenesis.
引用
收藏
页码:856 / 865
页数:10
相关论文
共 50 条
  • [31] Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease
    Markus Mandler
    Lauren Walker
    Radmila Santic
    Peter Hanson
    Ajeet Rijal Upadhaya
    Sean J. Colloby
    Christopher M. Morris
    Dietmar R. Thal
    Alan J. Thomas
    Achim Schneeberger
    Johannes Attems
    Acta Neuropathologica, 2014, 128 : 67 - 79
  • [32] Amyloid- Increases Tau by Mediating Sirtuin 3 in Alzheimer's Disease
    Yin, Junxiang
    Han, Pengcheng
    Song, Melissa
    Nielsen, Megan
    Beach, Thomas G.
    Serrano, Geidy E.
    Liang, Winnie S.
    Caselli, Richard J.
    Shi, Jiong
    MOLECULAR NEUROBIOLOGY, 2018, 55 (11) : 8592 - 8601
  • [33] Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease
    Pradeepkiran, Jangampalli Adi
    Baig, Javaria
    Islam, Md Ariful
    Kshirsagar, Sudhir
    Reddy, Hemachandra
    AGING AND DISEASE, 2025,
  • [34] Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer's disease
    Cheng, Yuan
    Ren, Jun-Rong
    Jian, Jie-Ming
    He, Chen-Yang
    Xu, Man-Yu
    Zeng, Gui-Hua
    Tan, Cheng-Rong
    Shen, Ying-Ying
    Jin, Wang-Sheng
    Chen, Dong-Wan
    Li, Hui-Yun
    Yi, Xu
    Zhang, Yuan
    Bu, Xian-Le
    Wang, Yan-Jiang
    TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)
  • [35] Amyloid-β-independent regulators of tau pathology in Alzheimer disease
    Rik van der Kant
    Lawrence S. B. Goldstein
    Rik Ossenkoppele
    Nature Reviews Neuroscience, 2020, 21 : 21 - 35
  • [36] Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
    Bloom, George S.
    JAMA NEUROLOGY, 2014, 71 (04) : 505 - 508
  • [37] Amyloid-β-independent regulators of tau pathology in Alzheimer disease
    van der Kant, Rik
    Goldstein, Lawrence S. B.
    Ossenkoppele, Rik
    NATURE REVIEWS NEUROSCIENCE, 2020, 21 (01) : 21 - 35
  • [38] Influence of amyloid-β on tau spread in Alzheimer disease explained
    Ian Fyfe
    Nature Reviews Neurology, 2022, 18 : 318 - 318
  • [39] Influence of amyloid-β on tau spread in Alzheimer disease explained
    Fyfe, Ian
    NATURE REVIEWS NEUROLOGY, 2022, 18 (06) : 318 - 318
  • [40] Alzheimer disease therapy—moving from amyloid-β to tau
    Ezio Giacobini
    Gabriel Gold
    Nature Reviews Neurology, 2013, 9 : 677 - 686